Showing results (151-160 of 715) with videos related to
Sort By:
Pageof 72
Blood|June 26, 2023
Representation of the population in need for pivotal clinical trials in lymphomasMycal Casey, Lorriane Odhiambo, Nidhi Aggarwal, et al.Clinical Lymphoma & Myeloma|March 27, 2007
Management of patients with newly diagnosed chronic myeloid leukemia: opportunities and challengesElias Jabbour, Jorge Cortes, Susan O'Brien, et al.Cancer Science|May 23, 2007
Sensitivity of human cells bearing oncogenic mutant kit isoforms to the novel tyrosine kinase inhibitor INNO-406Jingxuan Pan, Alfonso Quintás-Cardama, Taghi Manshouri, et al.Leukemia Research|April 6, 2012
Therapy with the histone deacetylase inhibitor pracinostat for patients with myelofibrosisAlfonso Quintás-Cardama, Hagop Kantarjian, Zeev Estrov, et al.Expert Review of Anticancer Therapy|March 13, 2015
The role of ponatinib in Philadelphia chromosome-positive acute lymphoblastic leukemiaDavid S Sanford, Hagop Kantarjian, Susan O'Brien, et al.Cancer|September 2, 2006
Novel approaches in the treatment of systemic mastocytosisAlfonso Quintas-Cardama, Ahmed Aribi, Jorge Cortes, et al.Blood|September 23, 2006
MK-0457, a novel kinase inhibitor, is active in patients with chronic myeloid leukemia or acute lymphocytic leukemia with the T315I BCR-ABL mutationFrancis J Giles, Jorge Cortes, Dan Jones, et al.Journal of Clinical Pharmacology|November 27, 2019
Population Pharmacokinetics of Glasdegib in Patients With Advanced Hematologic Malignancies and Solid TumorsSwan Lin, Naveed Shaik, Giovanni Martinelli, et al.American Journal of Cancer Research|February 7, 2024
Temporal trends in early-onset colorectal cancer incidence (2000-2020) by age group and five geographic regions in the state of GeorgiaMeng-Han Tsai, Justin X Moore, Daramola N Cabral, et al.Leukemia Research|May 4, 2004
Interleukin 11 May improve thrombocytopenia associated with imatinib mesylate therapy in chronic Myelogenous leukemiaPatricia Ault, Hagop Kantarjian, Mary Alma Welch, et al.Pageof 72